HC Surgical Specialists Limited (SGX: 1B1)

Singapore flag Singapore · Delayed Price · Currency is SGD
0.275
0.00 (0.00%)
At close: Nov 20, 2024
-8.33%
Market Cap 42.30M
Revenue (ttm) 19.05M
Net Income (ttm) 3.85M
Shares Out 153.81M
EPS (ttm) 0.03
PE Ratio 10.89
Forward PE n/a
Dividend 0.01 (5.19%)
Ex-Dividend Date Nov 8, 2024
Volume 10,000
Open n/a
Previous Close n/a
Day's Range n/a
52-Week Range 0.240 - 0.315
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Jan 10, 2025

About HC Surgical Specialists

HC Surgical Specialists Limited, an investment holding company, provides medical services primarily in Singapore. The company provides endoscopic procedures, including gastroscopies and colonoscopies; and general surgery services with a focus on colorectal procedures in a network of clinics. It also offers treatment services for other conditions, such as haemorrhoids, anal fissure, hernia, anal abscess, cholecystitis, anal fistula, appendicitis, colorectal cancer, lipomas, cysts, and gastric cancer, vein laser vascular, laparoscopy, and other g... [Read more]

Industry Offices and Clinics of Doctors of Medicine
Founded 2015
Country Singapore
Stock Exchange Singapore Exchange - Catalist
Ticker Symbol 1B1
Full Company Profile

Financial Performance

In 2024, HC Surgical Specialists's revenue was 19.05 million, a decrease of -1.03% compared to the previous year's 19.25 million. Earnings were 3.85 million, an increase of 31.76%.

Financial Statements

News

There is no news available yet.